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ABSTRACT
We developed a powerful expression system to
produce aptamers and other types of functional
RNA in yeast to examine their effects. Utilizing the
intron homing process, the aptamer-coding se-
quences were integrated into hundreds of rRNA
genes, and the aptamers were transcribed at high
levels by RNA polymerase I without any additional
promoter being introduced into the cell. We used
this system to express an aptamer against the
heat shock factor 1 (HSF1), a conserved transcrip-
tion factor responsible for mobilizing specific
genomic expression programs in response to
stressful conditions such as elevated temperature.
We observed a temperature sensitive growth retard-
ation phenotype and specific decrease of heat
shock gene expression. As HSF1 enables and
promotes malignant growth and metastasis in
mammals, and this aptamer binds yeast HSF1 and
its mammalian ortholog with equal affinity, the
results presented here attest to the potential of
this aptamer as a specific and effective inhibitor of
HSF1 activity.
INTRODUCTION
Due to their high aﬃnity and speciﬁcity, RNA aptamers
oﬀer advantages over several other types of reagents for
studying biological processes (1,2). Their application as
‘intramers’ is particularly useful to manipulate and
control protein function in the context of living cells or
organisms (3,4). However, their intracellular delivery is
not as straightforward. A tactic employed to circumvent
this problem is to deliver RNA aptamers as synthetic genes
(5). In mammalian cells, RNA polymerase III (Pol III)
promoters are often used to express aptamers and
observe their eﬀects (6); but the same type of promoter
when used in yeast was less successful (7). To address
this issue, we have developed an expression system to
achieve high levels of aptamer accumulation in the
baker’s yeast Saccharomyces cerevisiae. This system
utilizes the process of group I intron homing to insert an
aptamer-coding sequence into multiple copies of yeast
rDNA, so the aptamers can be produced through tran-
scription by RNA polymerase I (Pol I) without the require-
ment of additional promoters. Here, we report the use of
this system to produce an aptamer against heat shock
factor 1 (HSF1) to knock down the activity of this protein.
HSF1 is a major transcription regulator of the stress
response, and it is highly conserved among eukaryotes
(8,9). Under unfavorable conditions, and especially at
elevated temperatures, HSF1 activates the expression of
heat shock (HS) genes, producing HS proteins with chap-
eronin activity to repair cellular damage and boost cellular
resistancetofurtherinjury(10,11).Intriguingly,althoughit
presumablyevolvedtoenhancecellularsurvival,thismech-
anism can impede organismal survival under certain cir-
cumstances. In particular, HSF1 can aﬀect diverse
pathways as a powerful supporter of malignant transform-
ation (12). Therefore, in mammalian species, blocking the
activity of HSF1 may hold promise as a therapeutic
modality for the treatment of cancer. However, while
HSF1 is the dominant HS regulator in mammals and is
responsible for the maintenance of cancerous phenotype,
HSF has multiple isoforms that appear to have somewhat
specialized functions, which complicates the analysis of
HSF1 function (13–15). In addition, the diversity of
genetic backgrounds among various cancers makes it diﬃ-
cult to elucidate the mode of action of a potential
HSF-targeting therapeutic agent. In contrast, HSF
activity in yeast is encoded by a single gene, and the
HSF1 protein is essential for viability and vegetative
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toscreenforreagentscapableofinhibitingHSF1activityto
a suﬃcient degree to generate a systemic eﬀect (16,17).
Like many other transcription factors, HSF1 possesses
a DNA-binding domain and an activation domain.
Additionally, it has a trimerization domain and a
ﬂexible linker that collaborates with ﬂanking domains to
allow the homotrimer of HSF to bind avidly to a Heat
Shock Element (HSE) (8). Based on this molecular con-
ﬁguration, an eﬀective strategy for decoupling the tran-
scriptional response to HSF1 from its activation by a
HS stimulus is to mask the DNA binding and adjacent
domains, thereby preventing HSF from binding to the
HSEs. To this end, we generated an RNA aptamer for
HSF that competes with the HSE for binding to HSF1
(18). This aptamer, named AptHSF-RA1, binds yeast and
mammalian HSF1 equally well through interaction with
the DNA-binding domain and the ﬂanking linker region.
An in vitro transcription assay demonstrated the ability of
this aptamer to inhibit HS gene transcription (18). When
the HSF aptamer was expressed using the system
described here, we observed growth retardation of the
yeast cells under HS conditions. Consistent with this
cellular phenotype, we also observed a speciﬁc decrease
in the expression of genes activated by the HSF1.
MATERIALS AND METHODS
Plasmids and cloning
The group I intron trans-integration system is composed
of two plasmids, pCPIPpo (19), which carries the
Physarum homing endonuclease I-PpoI, and
pRSTtLSU1-ClaI (20), which carries the Tetrahymena
intron TtLSU1 (Tth.L1925) ﬂanked by yeast rDNA
sequence. pRSTtLSU1-ClaI has a unique ClaI site result-
ing from the mutation of four nucleotides in the P1 loop,
which is used for the insertion of the aptamer
AptHSF-RA1 in either monomeric or dimeric form. The
monomer insert was generated through bi-directional ex-
tension of an overlapping pair of oligonucleotide primers
purchased from Integrated DNA Technologies. The
dimeric insert was synthesized by GenScript. The se-
quences of these ClaI inserts are given below.
RA-1(M): 50-ATCGATGCGGCCGCGAATTCAACT
GCCTTCGGGCATCGCGATACAAAATTAAGTTGA
ACGCGAGTTCGCGGCCGCATCGAT-30. RA-1(D):
50-ATCGATGCGGCCGCGTGACGTTAATTCAACT
GCCTTCGGGCATCGCGATACAAAATTAAGTTGA
ACGCGAGTTTTCGTCATACTCCTTGGCATCGCG
ATACAAAATTAAGTTGAACGCGAGTTCTTCGGA
ATTCAACTGCCTTGGAGGCGCGGCCGCATCGA
T-30. The ligation product was transformed into the DH5a
Escherichia coli strain. Single colonies containing inserts
were conﬁrmed using polymerase chain reaction (PCR)
and veriﬁed by sequencing.
Yeast strains and intron homing
The parental strains for intron homing were W303-1A
(MATa; leu2-3,112; trp1-1; can1-100; ura3-1; ade2-1;
his3-11,15), YPH500 (MATa; ura3-52; lys2-801_amber;
ade2-101_ochre; trp1-D63; his3-D200; leu2-D1) and
BY4741(MATa; his3D1; leu2D0; met15D0; ura3D0). The
two plasmids for trans-integration were co-transformed
into the parental strains using the LiAc/ssDNA/PEG
method (21). Transformants carrying both plasmids were
identiﬁed on plates with SD—Ura–His media. To induce
intron homing, these transformants were cultured on
SGal–Ura–His plates and subcultured several times.
Samples were collected at several stages for colony PCR
to monitor the progress of homing until the process was
complete. The primers used in this assay have the follow-
ing sequences: E1 (a.k.a. JL83, #1803–1824 of yeast 25S
rDNA; downstream), 50-TCACCCCGGAATTGGTTT
ATCC-30; E2 (a.k.a. JL84, #2772–2753 of yeast 25S
rDNA; upstream), 50-CGAATGGGACCTTGAATG
C-30; I (R1), 50-CAATTTGACGGTCTTGCC-30.
Northern blot analysis was performed according to a
standard protocol (22) with the following probes
end-labeled using [g-
32P] adenosine triphosphate (ATP)
(GE Healthcare) and T4 polynucleotide kinase (NEB):
probe for rRNA, 50-CGAATGGGACCTTGAATGCTA
GAACGTGGAAAATGAATTCC-30; probe for aptamer,
50-ATCGATGCGGCCGCGAACTCGCGTTCAACTT
AATTTTGTATCGCGATGCCCGAAG-30. RNA
samples were run on a 1.67% agarose gel containing
2.2M formaldehyde in 1  MOPS buﬀer. Hybridization
was performed at 55 C overnight. The membrane was
washed with 0.1  saline-sodium citrate (SSC) containing
0.5% sodium dodecyl sulfate (SDS) at 65 C.
Yeast growth under normal and stressful conditions
Yeast strains were grown continuously at 30 C on SGal–
Ura–His plates. To examine their phenotypes under dif-
ferent conditions, strains were inoculated using several
serial dilutions into the following media and cultured at
the temperature indicated: SGal–Ura–His media at 22 C,
SGal–Ura–His media at 30 C, SGal–Ura–His media at
37 C, SGal–Ura–His media supplemented with 5mM
CuSO4 at 30 C, SGal–Ura–His media with 0.3mM
H2O2 at 30 C and SGal–Ura–His media with 1M
sorbitol at 30 C. The growth of the cell patches was
compared and recorded after 3–4 days’ incubation.
Reverse transcription (RT) and PCR
Liquid yeast culture grown at 22 C in log phase (O.D.
600=0.5–1.0.) was split into two equal parts. The ﬁrst
half was subjected to HS at 39 C for 20min, while the
other half remained at 22 C as the non-HS (NHS)
control. Both HS and NHS yeast cells were immediately
spun down and broken open with glass beads. Total RNA
was extracted using hot phenol (23). For RT, 4 pmol of
each primer was hybridized with 100ng of yeast total
RNA for each 10-ml reaction. The RNA was then
reverse-transcribed with SuperScript III reverse transcript-
ase (Invitrogen) at 37 C for 30min and 50 C for 30min,
followed by RNase cocktail treatment to eliminate the
remaining RNA. The product was diluted 200-fold, and
2ml of the diluted product was taken for further qPCR.
The qPCR was performed according to a protocol
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RNAs were used to plot the standard curves for each
gene tested. NHS genes such as U6 and ADH1 were
used as internal controls to normalize the RNA levels of
the HS genes and the aptamer being tested. The sequences
of the primers used are given below: SSA3F, 50-AGGGA
GGCAGAACGAGTTCAGG-30; SSA3R, 50-CTCCAGG
ACCTGCGCCGGCACC-30; HSP82F, 50-TCTGGGAAT
CCAACGCTGGTGG-30; HSP82R, 50-CAGAATGTCT
CTTGATAACTTCC-30; SSE2F, 50-CAATAACTCAGT
ACTAGCAGTTGCC-30; SSE2R, 50-ACCGCCGAACT
CCACTTCCACAC-30; HSP12F, 50-TGAAGCCAGACT
CTCAAAAGTC-30; HSP12R, 50-CTTCTTGGTTGGGT
CTTCTTCACC-30; ADH1DNF, 50-GGACATTGTCGG
TGCTGTTCTAAAGG-30; ADH1DNR, 50-ATTTCTGG
CAAGGTAGACAAGCCG-30; U6F, 50-GTTCGCGAA
GTAACCCTTCGTG-30; and U6R, 50-GAAATAAATC
TCTTTGTAAAACGG-30.
RESULTS
Conceptual design of an indirect aptamer delivery system
When aptamers are used inside cells as ‘intramers’ to
modulate protein function, it is important to balance the
expression levels of the aptamer and the target protein to
achieve the desired change in target function and cellular
phenotype. Several additional issues also need to be ad-
dressed, including the rate of aptamer production, correct-
ness of folding, stability and subcellular localization. Our
expression system aims primarily at generating a high level
of aptamer accumulation, so that the eﬀect of aptamers
can be easily observed and evaluated. It also ensures rea-
sonable stability of correctly folded aptamers and retains
the aptamers within the nucleus, the organelle that
harbors the protein targets of our aptamers. This system
comprises a set of molecular constructs that ferries the
aptamer-coding DNA to a speciﬁed location in the
middle of each rRNA gene. The strategy exploits unique
features of the nucleolar rRNA genes to achieve the goals
set above: in yeast, rRNAs are transcribed at a high level
by Pol I from about 150 copies of rDNA. Since each
rRNA gene contains an aptamer, the high-capacity tran-
scription of rRNA results in the production of a large
amount of aptamers as byproducts.
Utilization of the power of Pol I transcription in this
scheme requires the capability of inserting a heterologous
DNA fragment into all copies of the rDNA and ensuring
that normal rRNA production and maturation are not
aﬀected by this insertion. These problems were solved by
using a group I intron trans-integration process. In our
adaptation of this system, depicted in Figure 1A, we
combined components from three diﬀerent species. The
yeast S. cerevisiae served as the host, and harbored a
group I intron, TtLSU1, from the ciliate Tetrahymena
thermophila (25), and a homing endonuclease, I-PpoI,
from the slime mold Physarum polycephalum (26).
Homing of the group I intron into yeast rDNA was
driven in trans by I-PpoI, which was part of the intron
PpLSU3 (Ppo.L1925). This endonuclease recognizes a
15-bp site in each of the rDNA repeats on chromosome
12 and cleaves the DNA (27). PpLSU3 and TtLSU1 are
closely related. The Tetrahymena intron was chosen
because its self-splicing ribozyme is far more active then
that of the Physarum intron (28), and we found that it is
able to accommodate an inserted sequence and retain the
Figure 1. The indirect aptamer delivery system. (A) Trans-integration
of a group I intron. The three components, the host and the two
plasmids, are depicted. The arrow shows the transition of rDNA to
the intron-homed state caused by I-PpoI cleavage of the rDNA and
insertion of the intron-aptamer. (B) Schematic diagram of the
intron-aptamer. P4–P6 and P3–P9 signify the two catalytic domains
of the group I intron. The sequences shown as bases depict the ClaI
sites and the GC clamp extending from the P1 stem.
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coding sequence receives a ‘piggyback ride’ as an insert in
the group I intron, which integrates into these rDNA
repeats at the cleaved I-PpoI site. Using this system the
intron RNA accumulation can reach 2% of the total RNA
(19). As depicted in Figure 1B, we have designed a con-
struct in which the aptamer is introduced as an extension
of the P1 stem of the intron. At the interface between the
P1 stem and the aptamer, we used a ‘GC clamp’ (29) as a
structural insulator between the intron and the aptamer,
so that the splicing activity of the intron would not be
compromised and the aptamer would be well exposed.
Construction of yeast strains and conﬁrmation of
aptamer expression
To demonstrate the general utility of the method, we
tested it in three yeast strains commonly used in
laboratories, W303-1A, YPH500 and BY4741. To form
the aptamer-coding construct, a segment of DNA coding
for a minimized version of AptHSF-RA1 was inserted into
the sequence of the group I intron TtLSU1. The plasmid
pRSTtLSU1-RA1(M), carrying the gene for this
intron-aptamer, was co-transformed into the parental
yeast strains together with the plasmid pCPIPpo, which
carries the homing endonuclease I-PpoI under Gal 1,10
promoter control. In this arrangement, homing of the
intron was controlled by the induced expression of the
homing endonuclease. Since the insertion of the intron
would abolish the I-PpoI site in rDNA, the homing
process proceeded until all copies of rDNA had acquired
an intron.
To observe this process and to assess our aptamer
delivery system at the DNA level, we subcultured the
transformants several times and performed PCR with
two exon-speciﬁc primers (see Figure 2A, lanes labeled
EE) or an exon-speciﬁc primer paired with an intron-
speciﬁc primer (lanes labeled EI). Intron homing would
result in increased size of the EE fragment (from 870 to
1425bp). The 745bp EI fragment should only be
produced by rDNA with a homed intron. In Figure 2A,
we show the results of one completely homed clone
compared to one parental clone. Although the data
shown were generated using the W303-1A parental
strain, this experiment was performed in all three genetic
backgrounds with identical results.
To conﬁrm that this aptamer delivery system functioned
properly, two more tests at the RNA level were required.
First, the presence of the aptamer should not aﬀect the
expression of rRNA (the splicing of the group I intron
from rRNA transcripts should leave the mature rRNA
intact). Second, the level of intron-aptamer accumulation
should be suﬃciently high as to be comparable to the
rRNA level.
For these purposes, we prepared RNA from the homed
and parental strains, and measured the expression of the
rRNA and the aptamer using Northern blot analysis. An
oligonucleotide 41 bases in length covering the sequence of
the downstream exon at the PCR primer-annealing site
was used to detect the rRNA. To visualize the aptamer,
we used a probe 55 bases in length complementary to the
aptamer sequence. As shown in Figure 2B, the rRNA
probe revealed a band with identical mobility and inten-
sity in both parental (P) and homed (H) strains. The
aptamer probe detected a band in the homed strain
only, and the intensity of the band detected is close to
that of the rRNA band.
Cellular phenotypes caused by the HSF aptamer
The minimized ‘Core’ of the AptHSF-RA1 comprises a
three-way junction. Of the three stems connected to the
junction, Stem 1 contains an apical loop and an internal
A
EE EE EI EI M
Parental Homed
PH PH
rRNA AptHSF B
1000 bp
500 bp
1500 bp
700 bp
Figure 2. Functionality of the aptamer delivery system. (A) Intron
homing to rDNA as conﬁrmed by PCR. The primer annealing sites
on rDNA before and after homing is given at the top. The homing
of the intron to all rDNA is shown for one clone in the W303-1A
parental strain. EE designates bands produced by the two exonic
primers. EI designates bands produced by the exonic primer E1 and
the intronic primer I. ‘M’ indicates molecular weight markers. (B) RNA
expression as monitored by Northern blot analysis. ‘P’ indicates the
parental strain. ‘H’ indicates the homed strain. W303-1A was used
for this experiment.
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2 and 3 are short and both can serve as a point of inte-
gration with other structural or functional elements. As
shown in Figure 3A, in the TtLSU1-RA1(M) construct,
we connected Stem 3 with the P1 stem of the intron and
grafted a UUCG tetra-loop to the tip of Stem 2 to
maintain strand continuity, as this arrangement was
closer to the original full length version. Having success-
fully tested the expression system using the monomeric
construct, we also created a dimeric construct. To ensure
correct folding, an additional three-way junction was used
to join the two aptamers and the intron together. This
three-way junction was previously shown to be stable
among other variants (30) and used to present multiple
aptamers in molecular composites (31). As shown in
Figure 3A, we used either Stem 3 or 2 to connect the
aptamer to this additional three-way junction to form
the dimer RA1(D). This longer and more complex
sequence also helped demonstrate the general utility of
the aptamer expression system.
By preventing HSF1 from binding to its cognate DNA
sites, the aptamer AptHSF-RA1 was anticipated to com-
promise yeast survival at elevated temperatures. Prompted
by this hypothesis, we examined the growth rate of yeast
strains harboring the homed intron-aptamer at diﬀerent
temperatures. As shown in Figure 3B and C, the growth
rate of the homed strain and the parental strain did not
diﬀer signiﬁcantly when they were cultured at 22 C. As the
temperature increased, we observed moderate growth re-
tardation for the homed strain at 30 C. The most severe
phenotype was observed when the temperature was raised
to 37 C: the AptHSF(M) homed strain grew very slowly,
and the AptHSF(D) homed strain was not able to grow
under this HS condition. As an additional control, we also
tested homed strains with an intron carrying the antisense
sequence of the aptamer (R1 for the monomer and R2 for
the dimer). Growth of these strains was normal at all three
temperatures.
In addition to heat treatment, we also examined the
growth of the aptamer-expressing yeast under several
other stressful conditions. Because responses to these
non-heat stresses are not mediated by HSF1, these condi-
tions served as tests of aptamer speciﬁcity. As shown in
Figure 3B, exposure to hydrogen peroxide and hyper-
osmotic shock did not reveal any diﬀerence between the
aptamer-expressing strains and the antisense and parental
controls, although the growth of aptamer-expressing
strains appeared to be slightly aﬀected by CuSO4. These
results strongly indicated a causal relationship between
aptamer expression and a compromised response to
thermal stress.
Molecular phenotypes caused by the HSF aptamer
HSF1 plays a predominant role in the induction of HS
genes. The temperature sensitive phenotype of the
aptamer-expressing yeast strains described above led us
to predict that the HSF aptamer interfered with HSF ac-
tivation of at least some HS genes. To investigate the
mechanism underlying the systemic eﬀect of the
aptamer, we examined the mRNA level of three represen-
tative HS genes before and after heat treatment using
W303-1A stains expressing the AptHSF in either mono-
meric (M) or dimeric (D) forms, and compared them with
the strain harboring a control antisense version (R1 or R2)
of each construct. These three typical HS genes, SSA3,
HSP83 and SSE2, all have HSEs in the promoter and
are inducible by heat. As a control, we used the HSP12
gene, which is inducible by heat or other stresses but does
not contain typical HSEs in its promoter. If the aptamer
were eﬀective as an antagonist of HSF1, we would expect
that the levels of transcripts in aptamer-expressing strains
would be lower after HS than those in strains expressing
the antisense sequence.
B
Parental
AptHSF (M)
Antisense (R1)
22°C
30°C
37°C
Parental
AptHSF (M)
Antisense (R1)
Parental
AptHSF(M)
Antisense (R1)
0.3 mM H2O2
1 M sorbitol
5 mM CuSO4
C
Parental
AptHSF (D)
Antisense (R2)
22°C 30°C 37°C
A
Figure 3. Cellular phenotype of the inhibitory HSF aptamer. (A)
Predicted secondary structure of the monomer and the dimer being
expressed in yeast. The sequence between the two ClaI sites is shown.
Diﬀerent stems are indicated. The additional three-way junction used to
present the dimer is encircled. (B) Growth of the monomer (M)-ex-
pressing strain and control strains cultured on diﬀerent solid media
and under diﬀerent temperatures. ‘Antisense (R1)’ is a strain in
which the antisense sequence of the monomer was expressed. (C)
Growth of the dimer (D)-expressing strain and control strains
cultured under diﬀerent temperatures. ‘Antisense (R2)’ is a strain in
which the antisense sequence of the dimer was expressed. In both (B)
and (C), the parental strain was W303-1A. Patches in both (B) and (C)
were inoculated by 10-fold serial dilutions of yeast stock.
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signiﬁcant decrease in heat-induced expression of all three
typical HS genes in the strain expressing the AptHSF
monomer. The diﬀerence in ratios of mRNA levels
under HS and NHS conditions for the aptamer and anti-
sense strains for each gene analyzed indicated a
downregulation of HSF1 activity by the aptamer. In
contrast, the expression level of HSP12 was not changed
under either HS or NHS conditions. To conﬁrm this result
and compare the eﬃcacy of the monomer and dimer, we
used quantitative PCR (qPCR) to measure the mRNA
level of the same three HS genes in both monomer- and
dimer-expressing strains. Figure 4B shows a more
pronounced decrease in the level of these mRNAs in the
dimer-expressing strain than in the monomer-expressing
strain under both HS and NHS conditions. Notably, the
aptamer did not entirely inhibit HSF function, as in some
cases an increase in transcription still occurred after HS.
However, the resulting level of transcription apparently
did not produce suﬃcient proteins to enable survival of
the HS. In this experiment, we used the RNA polymerase
II-driven ethanol-inducible gene ADH1 and the Pol
III-driven constitutive gene U6 to normalize the data.
These genes were not induced by HS and were not in-
hibited by the aptamer.
DISCUSSION
HSF1 is a transcription factor involved in a wide variety of
biological processes, including stress responses. It is also a
master regulator of a cancer-enabling gene network and a
potential target for therapeutic inhibition in mammalians.
Interfering with DNA binding of a transcription factor is
an eﬃcient way to downregulate genes controlled by this
factor, a strategy demonstrated elegantly by an aptamer
for NF-kB (6,32,33). The aptamer used in the present
study was previously demonstrated to recognize the
DNA-binding domain and the adjacent linker region of
HSF with high aﬃnity (18). However, without an exhaust-
ive global proteomic assay, it is impossible to completely
rule out oﬀ-target eﬀects when an aptamer is used in an
assay involving cell extract or in living cells. Yeast exhibits
a general response of gene expression to stress as well as
speciﬁc genomic expression patterns for particular envir-
onmental conditions (34). Here, we showed that the
growth of aptamer-expressing yeast was severely impeded
by elevated temperature, but not by exposure to non-heat
stresses whose responses are not mediated by HSF1. In
parallel experiments, downregulation was observed in the
aptamer-expressing yeast for HS genes having HSEs in
their promoter but not for the control gene without
HSE. The congruence of cellular and molecular pheno-
types indicated that the speciﬁc knockdown of HS genes
in these strains was responsible for the systemic eﬀect.
Interestingly, the AptHSF-RA1 is also able to recognize
mammalian HSF1 (35), thus providing us with the exciting
prospect of further developing it as a potential anticancer
drug lead.
The forced expression of high levels of functional syn-
thetic RNAs in vivo requires the use of powerful pro-
moters to drive the transcription of genes encoding these
RNAs. To avoid shunting the transcripts into a
pre-mRNA pathway, Pol I- or Pol III-driven promoters
are often used for this purpose. However, a previous study
using the Pol III-driven promoter of the RNase P RNA
gene yielded aptamers equivalent to only  0.3% of en-
dogenous U6 RNA (7). Perhaps the high level of
SSA3
HSP82
SSE2
HSP12
ADH1
HS    NHS       HS           NHS
AptHSF (M) R1 A
B
SSA3
HSP82
SSE2
HS   +   - +   - +   - +   -
Strain MR 1 DR 2
Figure 4. Molecular phenotype of the inhibitory HSF aptamer. (A)
Eﬀect of aptamer monomer (M) on the level of HS genes measured
by conventional RT–PCR. ‘R1’ is a strain expressing the antisense
sequence of the aptamer monomer. HS (20min at 39 C). (B) Eﬀect
of both aptamer monomer (M) and dimer (D) on the level of HS
genes measured by RT–qPCR. ‘R2’ is a strain expressing the antisense
sequence of the aptamer dimer. The RNA level for each gene is pre-
sented as the ratio to the full HS induction level in the antisense control
strain, which is set to 1. The expression level for each gene is
normalized to that of ADH1. (We also used U6 to normalize the
data, and the data sets were consistent with each other.) The error
bars show the standard error from RT–qPCR experiments using
three independently heat-shocked yeast RNA preparations from the
same strain. In both panels the parental strain used was W303-1A.
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these RNA polymerases suggests that these transcription
systems are operating at close to full capacity, leaving less
room to accommodate additional genes. If this conjecture
were true, introducing large numbers of additional pro-
moters into the cell not only would produce insuﬃcient
amount of the synthetic RNA, but also might impede
the production of native transcripts by ‘soaking up’ the
limiting factors, thereby creating a situation in which
the real eﬀect of the synthetic RNA would be diﬃcult
to assess. In this study, we designed and constructed
an expression system in which the total number of Pol I
transcription initiation events in the cell remained un-
changed, which ensured that potentially limiting Pol I
transcription factors were not consumed by additional
promoters.
We achieved a high level of aptamer accumulation by
using a speciﬁc homing endonuclease to insert a
self-splicing intron containing the aptamer sequence into
every copy of the  150 highly expressed rRNA genes. In
general, homing endonucleases recognize sequences 14–
40bp in length (36) and are being developed as powerful
and precise tools to insert therapeutic genes into a chosen
location to circumvent the hazards of random insertion
technology (37–39). Our aptamer expression system
provided an innovative demonstration of their utility.
Using this approach, presumably other aptamers or
small RNAs could be delivered into host cells with
minimal collateral disruption. Performance of this
system may be aﬀected by several factors, including eﬃ-
ciency of homing and splicing of the intron as well as
activity of the aptamer. We have tested diﬀerent introns
and diﬀerent points of integration between the intron and
the aptamer to ﬁnd the optimal condition for homing as
described herein. But additional care should be taken to
design each intron-aptamer construct, as success hinges on
the functionality of both the aptamer and the intron in the
composite. In principle, both components should be cor-
rectly folded and the aptamer should be well exposed. For
these purposes, we introduced a long ‘GC-clamp’ (29)
between the aptamer and the intron. In the dimeric con-
struct, we further introduced a structurally stable
three-way junction (30) to enforce the folding modularity.
These design features can be used in other expression
constructs.
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